Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,369
Recruiting: 3,967
Ph III recruiting: 537
Growth YoY: +9.4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,405)

clinicaltrialsPublishedShowing 201–250 of 2,039 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07341737	SL-28 for Advanced Solid Tumours	recruiting	Phase 1 / Phase 2	60	Second Life TherapeuticsINDUSTRY	1	Sep 15, 2026	clinicaltrials
NCT07630168	Effects of Infusion Timing on Treatment Response in Solid Tumors(TIMED)	recruiting	Phase 2	238	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Sep 15, 2026	clinicaltrials